Publication | Closed Access

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

Open-label Phase 2HepatologyMedicineClinical TrialsPathologyCancer TreatmentOncologyRadiation OncologyHepatocellular CarcinomaAdvanced Hepatocellular CarcinomaHealth Sciences